You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠醫藥(01513.HK):克拉霉素片通過仿製藥質量和療效一致性評價
阿思達克 03-15 09:43
麗珠醫藥(01513.HK)公布,旗下麗珠集團麗珠製藥廠收到國家藥品監督管理局核准簽發的《藥品補充申請批准通知書》,麗珠製藥廠生產的克拉霉素片通過仿製藥質量和療效一致性評價。 公告稱,克拉霉素片是《國家基本醫療保險、工傷保險和生育保險藥品目錄》乙類品種,適用於治療對克拉霉素敏感的致病菌引起的感染,包括下呼吸道感染;上呼吸道感染;皮膚及軟組織感染;局部或彌散性感染;混合感染;根除幽門螺桿菌及牙源性感染。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account